XML 34 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments and Derivative Instruments (Tables)
3 Months Ended
Mar. 30, 2014
Financial Instruments and Derivative Instruments  
Schedule of fair value of financial assets and liabilities

 

 

 

Fair Value Measurements at March 30, 2014 Using:

 

 

 

 

 

Quoted Prices in
Active
Markets for Identical
Assets

 

Significant Other
Observable
Inputs

 

Significant
Unobservable
Inputs

 

 

 

Total

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

 

 

(in millions)

 

Assets

 

 

 

 

 

 

 

 

 

Plan asset for deferred compensation(1)

 

$

4.4

 

$

4.4

 

$

 

$

 

Total assets

 

$

4.4

 

$

4.4

 

$

 

$

 

Liabilities

 

 

 

 

 

 

 

 

 

Plan liability for deferred compensation(2)

 

$

4.4

 

$

4.4

 

$

 

$

 

Contingent consideration(3)

 

2.1

 

 

 

2.1

 

Total liabilities

 

$

6.5

 

$

4.4

 

$

 

$

2.1

 

 

 

 

Fair Value Measurements at December 31, 2013 Using:

 

 

 

 

 

Quoted Prices in
Active
Markets for Identical
Assets

 

Significant Other
Observable
Inputs

 

Significant
Unobservable
Inputs

 

 

 

Total

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

 

 

(in millions)

 

Assets

 

 

 

 

 

 

 

 

 

Plan asset for deferred compensation(1)

 

$

4.6

 

$

4.6

 

$

 

$

 

Total assets

 

$

4.6

 

$

4.6

 

$

 

$

 

Liabilities

 

 

 

 

 

 

 

 

 

Plan liability for deferred compensation(2)

 

$

4.6

 

$

4.6

 

$

 

$

 

Contingent consideration(3)

 

4.4

 

 

 

4.4

 

Total liabilities

 

$

9.0

 

$

4.6

 

$

 

$

4.4

 

 

 

(1)         Included on the Company’s consolidated balance sheet in other assets (other, net).

(2)         Included on the Company’s consolidated balance sheet in accrued compensation and benefits.

(3)         Included on the Company’s consolidated balance sheet in accrued expenses and other liabilities as of March 30, 2014 and in other noncurrent liabilities and accrued expenses and other liabilities as of December 31, 2013.

Summary of the changes in fair value of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3)

 

 

 

Balance

 

Purchases,

 

Total realized and
unrealized (gains)
losses included in:

 

Balance

 

 

 

December 31,
2013

 

sales,
settlements, net

 

Net earnings
adjustments

 

Comprehensive
income

 

March 30,
2014

 

 

 

(in millions)

 

Contingent consideration

 

$

4.4

 

$

(2.2

)

$

 

$

(0.1

)

$

2.1

 

Carrying amount and estimated fair market value of the company's long-term debt, including current portion

 

 

 

March 30,

 

December 31,

 

 

 

2014

 

2013

 

 

 

(in millions)

 

Carrying amount

 

$

307.3

 

$

307.7

 

Estimated fair value

 

$

332.3

 

$

333.4